Perhaps one of the reasons that ON with anti-AQP4-specific antibodies might initially be more prevalent than LETM in NMO is that the tissues of the optic nerve are more sensitive to volume changes induced by AQP4 dysfunction than other areas of the CNS [19]. The gene discussed is AQP4; the disease is neuromyelitis optica.